ArticleBiomedicines2023
Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate Cancer.
Siddhant Bhoir et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleBiomedicines2023
Siddhant Bhoir et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.